Drug Screening Using Novel IMD in Renal Cell Carcinoma
Condition(s):Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Kidney CancerLast Updated:June 22, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma; Kidney CancerLast Updated:June 22, 2023Recruiting
Condition(s):Myocardial IschemiaLast Updated:January 15, 2019Terminated
Condition(s):Breast Cancer; ER-positive Breast Cancer; HER2-negative Breast Cancer; Metastatic Breast CancerLast Updated:August 21, 2023Recruiting
Condition(s):Breast Cancer; Metastatic CancerLast Updated:July 26, 2022Recruiting
Condition(s):Coronary Artery DiseaseLast Updated:April 23, 2013Completed
Condition(s):Lymphangioleiomyomatosis (LAM)Last Updated:January 20, 2022Completed
Condition(s):Calcified Coronary Artery DiseaseLast Updated:January 9, 2024Recruiting
Condition(s):Breast Neoplasm; Breast Cancer; Hormone Receptor Positive Tumor; HER2-negative Breast Cancer; Advanced Breast CancerLast Updated:February 6, 2024Recruiting
Condition(s):Coronary StenosisLast Updated:May 8, 2023Completed
Condition(s):Coronary Artery Disease; Native Coronary Artery Stenosis; Cardiovascular DiseasesLast Updated:February 22, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.